{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:19:42Z","timestamp":1791685182595,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-alcoholic steatohepatitis (NASH) is a highly prevalent chronic liver disease. Here, we have investigated whether BAR502, a non-bile acid, steroidal dual ligand for FXR and GPBAR1, reverses steato-hepatitis in mice fed a high fat diet (HFD) and fructose. After 9 week, mice on HFD gained \u224830% of b.w (P\u2009&lt;\u20090.01 versus na\u00efve) and were insulin resistant. These overweighting and insulin resistant mice were randomized to receive HFD or HFD in combination with BAR502. After 18 weeks, HFD mice developed NASH like features with severe steato-hepatitis and fibrosis, increased hepatic content of triacylglycerol and cholesterol and expression of SREPB1c, FAS, ApoC2, PPAR\u03b1 and \u03b3, \u03b1-SMA, \u03b11 collagen and MCP1 mRNAs. Treatment with BAR502 caused a \u224810% reduction of b.w., increased insulin sensitivity and circulating levels of HDL, while reduced steatosis, inflammatory and fibrosis scores and liver expression of SREPB1c, FAS, PPAR\u03b3, CD36 and CYP7A1 mRNA. BAR502 increased the expression of SHP and ABCG5 in the liver and SHP, FGF15 and GLP1 in intestine. BAR502 promoted the browning of epWAT and reduced liver fibrosis induced by CCl\n                    <jats:sub>4<\/jats:sub>\n                    . In summary, BAR502, a dual FXR and GPBAR1 agonist, protects against liver damage caused by HFD by promoting the browning of adipose tissue.\n                  <\/jats:p>","DOI":"10.1038\/srep42801","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T05:07:24Z","timestamp":1487221644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Adriana","family":"Carino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annibale","family":"Donini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"BFsrep42801_CR1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","volume":"6","author":"ZA Sherif","year":"2016","unstructured":"Sherif, Z. A. et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations. Dig Dis Sci. 6, 1214\u201325 (2016).","journal-title":"Dig Dis Sci"},{"key":"BFsrep42801_CR2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","volume":"21","author":"S Fiorucci","year":"2015","unstructured":"Fiorucci, S. & Distrutti, E. Bile Acid-Activated Receptors, Intestinal Microbiota and the Treatment of Metabolic Disorders. Trends Mol Med 21, 702\u201314 (2015).","journal-title":"Trends Mol Med"},{"key":"BFsrep42801_CR3","first-page":"1","volume":"26","author":"G Mintziori","year":"2016","unstructured":"Mintziori, G. & Polyzos, S.-A. Emerging and future therapies for nonalcoholic steatohepatitis in adults. Expert Opin Pharmacother 26, 1\u201310 (2016).","journal-title":"Expert Opin Pharmacother"},{"key":"BFsrep42801_CR4","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.2174\/1381612819666131206111352","volume":"20","author":"M Rosselli","year":"2014","unstructured":"Rosselli, M. et al. The metabolic syndrome and chronic liver disease. Curr Pharm Des 20, 5010\u201324 (2014).","journal-title":"Curr Pharm Des"},{"key":"BFsrep42801_CR5","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy, G., Brunt, E.-M. & Caldwell, S.-H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J. Hepatol 56, 1384\u20131391 (2012).","journal-title":"J. Hepatol"},{"key":"BFsrep42801_CR6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2006.10.021","volume":"46","author":"A Rubio","year":"2007","unstructured":"Rubio, A. et al. Identification of a gene-pathway associated with non-alcoholic steatohepatitis. J Hepatol 46, 708\u2013718 (2007).","journal-title":"J Hepatol"},{"key":"BFsrep42801_CR7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61, 1547\u20131554 (2015).","journal-title":"Hepatology"},{"key":"BFsrep42801_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389\u2013397 (2015).","journal-title":"Gastroenterology"},{"key":"BFsrep42801_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","volume":"6","author":"G-C Farrell","year":"2012","unstructured":"Farrell, G.-C., van Rooyen, D., Gan, L. & Chitturi, S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver 6, 149\u2013171 (2012).","journal-title":"Gut Liver"},{"key":"BFsrep42801_CR10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E.-A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism Clinical and Experimental 65, 1038\u20131048 (2016).","journal-title":"Metabolism Clinical and Experimental"},{"key":"BFsrep42801_CR11","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","volume":"18","author":"Y Takahashi","year":"2012","unstructured":"Takahashi, Y., Soejima, Y. & Fukusato, T. Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol. 18, 2300\u20138 (2012).","journal-title":"World J Gastroenterol"},{"key":"BFsrep42801_CR12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","volume":"151","author":"A Teufel","year":"2016","unstructured":"Teufel, A. et al. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Diseaseand Liver Tissues From Patients. Gastroenterology 151, 513\u2013525 (2016).","journal-title":"Gastroenterology"},{"key":"BFsrep42801_CR13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","volume":"52","author":"R Kohli","year":"2010","unstructured":"Kohli, R. et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934\u2013944 (2010).","journal-title":"Hepatology"},{"key":"BFsrep42801_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plipres.2009.11.001","volume":"49","author":"S Fiorucci","year":"2010","unstructured":"Fiorucci, S., Cipriani, S., Baldelli, F. & Mencarelli, A. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 49, 171\u201385 (2010).","journal-title":"Prog Lipid Res"},{"key":"BFsrep42801_CR15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","volume":"30","author":"S Fiorucci","year":"2009","unstructured":"Fiorucci, S., Mencarelli, A., Palladino, G. & Cipriani, S. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.Trends Pharmacol Sci 30, 570\u201380 (2009).","journal-title":"Trends Pharmacol Sci"},{"key":"BFsrep42801_CR16","doi-asserted-by":"crossref","first-page":"H272","DOI":"10.1152\/ajpheart.01075.2008","volume":"296","author":"A Mencarelli","year":"2009","unstructured":"Mencarelli, A., Renga, B., Distrutti, E. & Fiorucci, S. Antiatherosclerotic effect of farnesoid X receptor. Am J Physiol Heart Circ Physiol 296, H272\u201381 (2009).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep42801_CR17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","volume":"51","author":"S Cipriani","year":"2010","unstructured":"Cipriani, S., Mencarelli, A., Palladino, G. & Fiorucci, S. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats. J Lipid Res 51, 771\u201384 (2010).","journal-title":"J Lipid Res"},{"key":"BFsrep42801_CR18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"B-A Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri, B.-A. et al. NASH Clinical Research Network. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385, 956\u201365 (2015).","journal-title":"Lancet"},{"key":"BFsrep42801_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrd4592","volume":"14","author":"CB Nanthakumar","year":"2015","unstructured":"Nanthakumar, C. B. et al. Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nature Reviews Drug Discovery 14, 693\u2013720 (2015)","journal-title":"Nature Reviews Drug Discovery"},{"key":"BFsrep42801_CR20","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1021\/jm501273r","volume":"57","author":"C Festa","year":"2014","unstructured":"Festa, C. et al. Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands. J Med Chem 57, 8477\u201395 (2014).","journal-title":"J Med Chem"},{"key":"BFsrep42801_CR21","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","volume":"127","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci, S. et al. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127, 1497\u2013512 (2004).","journal-title":"Gastroenterology"},{"key":"BFsrep42801_CR22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"D-E Kleiner","year":"2005","unstructured":"Kleiner, D.-E. et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u201321 (2005).","journal-title":"Hepatology"},{"key":"BFsrep42801_CR23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/mol.106.023820","volume":"70","author":"G Rizzo","year":"2006","unstructured":"Rizzo, G. et al. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo . Mol Pharmacol 70, 1164\u201373 (2006).","journal-title":"Mol Pharmacol"},{"key":"BFsrep42801_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.chroma.2014.10.064","volume":"1371","author":"C John","year":"2014","unstructured":"John, C. et al. A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids. J Chromatogr A. 1371, 184\u201395 (2014).","journal-title":"J Chromatogr A"},{"key":"BFsrep42801_CR25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2012.03.008","volume":"36","author":"V Keitel","year":"2012","unstructured":"Keitel, V. & H\u00e4ussinger, D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol. 36, 412\u20139 (2012).","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"BFsrep42801_CR26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2012.09.055","volume":"144","author":"F Alemi","year":"2013","unstructured":"Alemi, F. et al. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 144, 145\u201354 (2013).","journal-title":"Gastroenterology"},{"key":"BFsrep42801_CR27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","volume":"329","author":"S Katsuma","year":"2005","unstructured":"Katsuma, S., Hirasawa, A. & Tsujimoto, G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329, 386\u201390 (2005).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep42801_CR28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin, B. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 6, 517\u201326 (2000).","journal-title":"Mol Cell."},{"key":"BFsrep42801_CR29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484\u20139 (2006).","journal-title":"Nature"},{"key":"BFsrep42801_CR30","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1096\/fj.11-195701","volume":"26","author":"B Renga","year":"2012","unstructured":"Renga, B. et al. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J. 26, 3021\u201331 (2012).","journal-title":"FASEB J"},{"key":"BFsrep42801_CR31","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","volume":"147","author":"T Lieu","year":"2014","unstructured":"Lieu, T. et al. The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. Gastroenterology 147, 1417\u201328 (2014).","journal-title":"Gastroenterology"},{"key":"BFsrep42801_CR32","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1194\/jlr.M008128","volume":"51","author":"L Jakulj","year":"2010","unstructured":"Jakulj, L. et al. ABCG5\/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis. J Lipid Res 51, 3016\u201323 (2010).","journal-title":"J Lipid Res"},{"key":"BFsrep42801_CR33","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/scisignal.272re3","volume":"2","author":"R-L Silverstein","year":"2009","unstructured":"Silverstein, R.-L. & Febbraio, M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2, re3. doi: 10.1126\/scisignal.272re3 (2009).","journal-title":"Sci Signal"},{"key":"BFsrep42801_CR34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","volume":"60","author":"M-E Miquilena-Colina","year":"2011","unstructured":"Miquilena-Colina, M.-E. et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 60, 1394\u2013402 (2011).","journal-title":"Gut"},{"key":"BFsrep42801_CR35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","volume":"49","author":"K-H Song","year":"2009","unstructured":"Song, K.-H., Li, T., Owsley, E., Strom, S. & Chiang, J.-Y. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 49, 297\u2013305 (2009).","journal-title":"Hepatology"},{"key":"BFsrep42801_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/adip.18951","volume":"1","author":"K-L Townsend","year":"2012","unstructured":"Townsend, K.-L. & Tseng, Y.-H. Brown adipose tissue: recent insights into development, metabolic function and therapeutic potential. Adipocyte 1, 13\u201324 (2012).","journal-title":"Adipocyte"},{"key":"BFsrep42801_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cmet.2010.03.004","volume":"11","author":"A Frontini","year":"2010","unstructured":"Frontini, A. & Cinti, S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab 11, 253\u20136 (2010).","journal-title":"Cell Metab"},{"key":"BFsrep42801_CR38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","volume":"150","author":"J Wu","year":"2012","unstructured":"Wu, J. et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366\u2013376 (2012).","journal-title":"Cell"},{"key":"BFsrep42801_CR39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-201X.2003.01159.x","volume":"178","author":"C Erlanson-Albertsson","year":"2003","unstructured":"Erlanson-Albertsson, C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand 178, 405\u201312 (2003).","journal-title":"Acta Physiol Scand"},{"key":"BFsrep42801_CR40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cmet.2007.06.001","volume":"6","author":"P Seale","year":"2007","unstructured":"Seale, P. et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab 6, 38\u201354 (2007).","journal-title":"Cell Metab"},{"key":"BFsrep42801_CR41","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1074\/jbc.M109.053942","volume":"285","author":"N Petrovic","year":"2010","unstructured":"Petrovic, N. et al. Chronic peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285, 7153\u20137164 (2010).","journal-title":"J Biol Chem"},{"key":"BFsrep42801_CR42","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.0610416104","volume":"104","author":"K Almind","year":"2007","unstructured":"Almind, K., Manieri, M., Sivitz, W. I., Cinti, S. & Kahn, C. R. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci USA 104, 2366\u201371(2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep42801_CR43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nutres.2012.06.020","volume":"32","author":"K-B de Queiroz","year":"2012","unstructured":"de Queiroz, K.-B. et al. Endurance training blocks uncoupling protein 1 up-regulation in brown adipose tissue while increasing uncoupling protein 3 in the muscle tissue of rats fed with a high-sugar diet. Nutr Res 32, 709\u201317 (2012).","journal-title":"Nutr Res"},{"key":"BFsrep42801_CR44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2006.04.002","volume":"3","author":"M Uldry","year":"2006","unstructured":"Uldry, M. et al. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 3, 333\u2013341 (2006).","journal-title":"Cell Metab"},{"key":"BFsrep42801_CR45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","volume":"360","author":"A-M Cypess","year":"2009","unstructured":"Cypess, A.-M. et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360, 1509\u20131517 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep42801_CR46","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","volume":"360","author":"K-A Virtanen","year":"2009","unstructured":"Virtanen, K.-A. et al. Functional brown adipose tissue in healthy adults. N Engl J Med 360, 1518\u20131525 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep42801_CR47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2011.04.001","volume":"17","author":"A-J Whittle","year":"2011","unstructured":"Whittle, A.-J., L\u00f3pez, M. & Vidal-Puig, A. Using brown adipose tissue to treat obesity\u2014the central issue. Trends Mol Med 17, 405\u2013411 (2011).","journal-title":"Trends Mol Med"},{"key":"BFsrep42801_CR48","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1074\/jbc.M107955200","volume":"277","author":"B-D Fink","year":"2002","unstructured":"Fink, B.-D. et al. UCP2-dependent proton leak in isolated mammalian mitochondria. J Biol Chem 277, 3918\u201325 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep42801_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1292\/jvms.13-0359","volume":"76","author":"H Asano","year":"2014","unstructured":"Asano, H. et al. Induction of beige-like adipocytes in 3T3-L1 cells. J Vet Med Sci 76, 57\u201364 (2014).","journal-title":"J Vet Med Sci"},{"key":"BFsrep42801_CR50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.phrs.2016.07.040","volume":"111","author":"S Fiorucci","year":"2016","unstructured":"Fiorucci, S. & Distrutti, E. Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension. Pharmacol Res. 111, 749\u2013756 (2016).","journal-title":"Pharmacol Res."},{"key":"BFsrep42801_CR51","doi-asserted-by":"crossref","first-page":"e0141082","DOI":"10.1371\/journal.pone.0141082","volume":"10","author":"B Renga","year":"2015","unstructured":"Renga, B. et al. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT\/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1. PLoS One 10, e0141082 (2015).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42801.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42801","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42801.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:19:10Z","timestamp":1671826750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,27]]}},"alternative-id":["BFsrep42801"],"URL":"https:\/\/doi.org\/10.1038\/srep42801","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]},"assertion":[{"value":"14 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"42801"}}